Table 3.
Demographic and clinical characteristics in the study population at enrolment (n = 63)
| Groups a | 0 | 1 | 2 | 3 | 4 | 5 | 6 | Total |
|---|---|---|---|---|---|---|---|---|
| EcoVag® | Lc 4R5 | Lc 23B33 | Lc 21M49 | Lg14869 | Lg 14869 | LaciBios® | ||
| Lg 14869 | Lg 20M39 | Lg 6M9 | Lg 6M9 | Lr 14870 | Lr 14870 | Lr GR-1 | ||
| Lr 14870 | Lj 22B42 | Lj 12B1 | Lc 8R6 | Lg 15527 | Lg 15527 | Lr RC-14 | ||
| Vaginal | Vaginal | Vaginal | Vaginal | Vaginal | Oral | Oral | ||
| n = 9 | n = 12 | n = 10 | n = 10 | n = 9 | n = 4 | n = 9 | n = 63 | |
| Mean age (range) | 34.2 (19-55) | 36.6 (26-48) | 35.3 (25-45) | 32.7 (25-39) | 33.3 (21-46) | 33.0 (25-38) | 34.7 (21-45) | 34.2 (19-55) |
| Patients with history of BV (no.) | 3 | 6 | 5 | 5 | 3 | 0 | 1 | 23 (36.5%) |
| Patients with Mobiluncus on microscopy (no.) | 4 | 6 | 5 | 3 | 4 | 2 | 2 | 26 (41.3%) |
| Length of symptoms of BV (months, mean and range)c | 10.7 (1-24) | 10.7 (1-48) | 14.1 (1-60) | 7.9 (1-48) | 18.3 (2-60) | 3.3 (2-6) | 9.5 (1-24) | 11.3 (1-60) |
| Patients with new relation (no.) | 8 | 6 (2 divorced) | 8 (1 divorced) | 6 (2 divorced) | 6 | 3 (1 divorced) | 4 | 36 (57.1%) |
| New relation before symptoms appear (no.) | 8 | 6 | 8 | 6 | 6 | 3 | 3 | 35 (55.6%) |
| Length of symptoms of BV among women with new relation (months, mean and range) | 10.5(1-24) | 6.5 (1-12) | 14.4 (1-60) | 4.5 (2-11) | 11.3 (2-46) | 3.3 (2-6) | 11.2 (1-24) | 8.2 (1-46) |
a Each group are given capsules with a mix of two or three Lactobacillus strains: Lg, L. gasseri; Lr, L. rhamnosus; Lc, L. crispatus; Lj, L. jenseneii
b Capsules contain the two strains from EcoVag® plus an additional strain, L. gasseri DSM 15527, belonging to Bifodan A/S
c One patient in group 3, 5, 6 and two patients in group 4 could not give any information since how long time she had symptoms of BV.